Bionexus Gene Lab Corp is a biotechnology company focused on the development and commercialization of innovative genomic solutions and technologies
The company specializes in harnessing the power of genetic research to create advanced diagnostic tools and therapeutic products aimed at improving health outcomes. Through its cutting-edge platforms, Bionexus aims to enhance our understanding of genetic diseases and facilitate precision medicine, thereby contributing to more effective treatments and personalized healthcare solutions.
Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as a treasury reserve asset on Wednesday, following the cryptocurrency’s inclusion in th
